Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
about
Three-dimensional analysis of vascular development in the mouse embryoAngiopoietins 3 and 4: diverging gene counterparts in mice and humansCardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular systemHomeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFInhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteinsVascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisESDN, a novel neuropilin-like membrane protein cloned from vascular cells with the longest secretory signal sequence among eukaryotes, is up-regulated after vascular injuryDirect reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vesselsMammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulationAngiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrinsVEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and ratsNeuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)CCR3 is a target for age-related macular degeneration diagnosis and therapySelective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cellsProteolytic processing regulates receptor specificity and activity of VEGF-C.A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol estersHypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarkerPlacental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient miceThe LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesisDual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesisAssociation between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicityEdg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturationSpatiotemporal control over growth factor signaling for therapeutic neovascularizationVE-statin, an endothelial repressor of smooth muscle cell migrationThe VEGF IRESes are differentially susceptible to translation inhibition by miR-16VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesisSrc-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumorsVascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsLack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesisRegulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIPDelta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sproutingAngiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcersThe vascular endothelial growth factor (VEGF) family: angiogenic factors in health and diseaseTherapeutic angiogenesis for cardiovascular diseasePathways for aberrant angiogenesis in pancreatic cancerAngiogenesis in male breast cancer
P2860
Q21144270-7B37D130-A5F7-47A7-9D3D-2589399204ECQ22008836-3771CF78-9B26-4E85-B901-86C9AF1E3E6AQ22253240-0E91D306-BF24-46C9-AD5B-19EB0D6978FDQ22253478-C312B2DA-C048-4027-8F21-63E2ACF2E56AQ22254113-2344FC38-E794-4294-89C2-01E04DF2E3BCQ22305863-FBD2A14C-8880-4F63-A18E-7F1430D43E46Q24291432-9D045E29-8138-4A4D-8C87-913BC2CD2AE1Q24295157-0F8E59B9-9F0A-454F-82C1-204F9C67448AQ24298432-A4D2AF9F-EE00-4FA5-8F29-F7557F149D38Q24311459-95F94E70-75FD-40C0-9189-2954D21A5E93Q24312100-DBB56D84-F7A6-4687-AD85-D28C38001890Q24313613-1F216E23-B36B-4E9C-AA27-6EF42CE2F10EQ24321792-7CBE375B-AD0A-44ED-B33E-5FD0692F9783Q24338258-103B0F0B-FCAA-4837-BEFB-52104AA04D4CQ24531302-21C36B57-6BE5-4305-ABCC-0C43FC3D2CC0Q24532025-0B21DBCA-B565-46BF-A4C5-12AA3D9CD94DQ24532314-E9210247-5197-48BC-BAA8-4A162B7E2992Q24559732-F8EB3FE6-8853-4733-85F0-DDE249E1E551Q24595773-45E96486-75CB-4CC7-9B9A-7958A3BF0297Q24601085-8C52390A-7F47-40B8-86C6-9ED023E9B86BQ24604636-2E815938-0085-4EE0-B898-0A51E4FD1531Q24607154-C52A78EC-C8A0-4E4B-BAC7-563DCD71CD61Q24608892-DCE231A0-5C4B-4B26-9086-8DB614784B15Q24626427-AADFA08B-B5CD-47C0-8E6D-AECE411D0DDBQ24629370-6BD055BD-76EE-47A4-978C-EDCDD5CDC0FDQ24641819-4A4329D5-6336-491E-BFA9-9F171A2F7D1FQ24644976-2ABB97CF-F73E-4A24-B469-389B8819C537Q24647478-AD7139BC-15BF-497C-A988-CE590D9CCC36Q24658393-75A53A11-2DEF-4FBC-B783-C534A66C5CC0Q24673519-D3046311-1DA5-416A-9C92-39837E493419Q24678647-9B0B70E2-FE5D-4DF1-831C-49F19698E37FQ24679724-283AFCB3-F984-43D6-8813-0A8D86D280C5Q24681191-7E824261-2EE8-47D2-ADE4-D05AD628EA78Q24683762-FD0943F9-84D2-4677-9A29-6A4721EC62CDQ24685542-558E25BD-1EB0-4069-B700-581AAB7A7D53Q24793891-43C512BD-7B93-4B65-8A4A-D0593BC0D68CQ24796165-BE993194-0DEC-4BAC-86CE-F91B0A2E1B97Q24799337-20AA79C8-C02C-443E-BFB1-C1A90C914BFEQ24800215-8DF94BDE-20BE-4588-AF06-A44FA7F4FD22Q24803467-41B9C7B8-8C8A-49C1-AE7F-A2ED2EA2FE1B
P2860
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@ast
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@en
type
label
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@ast
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@en
prefLabel
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@ast
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@en
P2093
P50
P3181
P356
P1433
P1476
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
@en
P2093
Carmeliet P
Declercq C
Eberhardt C
Ferreira V
Gertsenstein M
Kieckens L
P2888
P304
P3181
P356
10.1038/380435A0
P407
P577
1996-04-01T00:00:00Z
P5875
P6179
1034005847